Abstracts tagged "depression"

Abstract Number: 2646 • 2014 ACR/ARHP Annual Meeting
Mood Disorders in Systemic Lupus Erythematousus (SLE): Results from an International, Inception Cohort Study
John G. Hanly for the Systemic Lupus International Collaborating Clinics¹, Li Su², Murray Urowitz³, Juanita Romero-Diaz⁴, Caroline Gordon⁵, Sang-Cheol Bae⁶, Sasha R Bernatsky⁷, Ann E. Clarke⁸, Daniel J. Wallace⁹, Joan T. Merrill¹⁰, David A. Isenberg¹¹, Anisur Rahman¹², Ellen M. Ginzler¹³, Paul Fortin¹⁴, Dafna D. Gladman¹⁵, Jorge Sanchez-Guerrero¹⁶, Michelle Petri¹⁷, Ian Bruce¹⁸, Mary Anne Dooley¹⁹, Rosalind Ramsey-Goldman²⁰, Cynthia Aranow²¹, Graciela S. Alarcon²², Barri J. Fessler²³, Kristján Steinsson²⁴, Ola Nived²⁵, Gunnar K. Sturfelt²⁵, Susan Manzi²⁶, Munther A. Khamashta²⁷, Ronald F. van Vollenhoven²⁸, Asad Zoma²⁹, Manuel Ramos-Casals³⁰, Guillermo Ruiz-Irastorza³¹, S. Sam Lim³², Thomas Stoll³³, Murat Inanc³⁴, Kenneth C. Kalunian³⁵, Diane L. Kamen³⁶, Peter Maddison³⁷, Christine A. Peschken³⁸, Søren Jacobsen³⁹, Anca Askanase⁴⁰, Jill P. Buyon⁴¹, Chris Theriault⁴², Kara Thompson⁴² and Vernon Farewell², ¹Division of Rheumatology, Dalhousie University and Capital Health, Nova Scotia, Canada, Halifax, NS, Canada, ²MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, United Kingdom, ³Medicine, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutricion, Mexico city, Mexico, ⁵Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁶Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁷Division of Rheumatology and Clinical Epidemiology, McGill University, Montreal, Quebec, QC, Canada, ⁸Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ⁹Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, ¹⁰Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹¹Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, ¹²Centre for Rheumatology Research, University College London, London, United Kingdom, ¹³Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY, ¹⁴Medicine, Division of Rheumatology, Centre Hospitalier Universitaire de Quebec et Universite Laval, Quebec, QC, Canada, ¹⁵University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ¹⁶Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ¹⁷Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ¹⁸Kellgren Centre for Rheum, Arthritis Research UK Epidemiology Unit, Institution of Inflammation and Repair, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, ¹⁹Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ²⁰Rheumatology, Northwestern University and Feinberg School of Medicine, Chicago, IL, ²¹Feinstein Institute for Medical Research, Mahasset, NY, ²²Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ²³Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ²⁴Centre for Rheumatology Research, Landspital University Hospital, Reykjavik, Iceland, ²⁵Department of Rheumatology, University Hospital Lund, Lund, Sweden, ²⁶Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ²⁷Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom, ²⁸Unit for clinical therapy research (ClinTrid), Karolinska Institute, Stockholm, Sweden, ²⁹Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, United Kingdom, ³⁰Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ³¹Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain, ³²Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ³³Kantonsspital Geissbergstr, Schaffhausen, Switzerland, ³⁴Rheumatology, Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, ³⁵UCSD School of Medicine, La Jolla, CA, ³⁶Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, ³⁷Ysbyty Gwynedd Bangor, North Wales, United Kingdom, ³⁸University of Manitoba, Canada, Winnipeg, MB, Canada, ³⁹Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, ⁴⁰Columbia University Medical Center, New York, NY, ⁴¹Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁴²Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
Background/Purpose: Neuropsychiatric (NP) events in patients with SLE include mood disorders. We determined the frequency, characteristics, clinical and autoantibody associations of mood disorders in a…
Abstract Number: 2397 • 2014 ACR/ARHP Annual Meeting
Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study
Marlène Genty¹, Marie Kostine², Elodie Ardouin³, Bernard Combe⁴ and Cédric Lukas⁵, ¹RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, ²Rheumatology, CHU Pellegrin, Bordeaux, France, ³Rheumatology, Limoges University Hospital, Limoges, France, ⁴Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ⁵Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France
Background/Purpose The functional burden of disease in Rheumatoid arthritis (RA) patients, mainly caused by inflamed joints, is often worsened by extra-articular manifestations, among which asthenia remains…
Abstract Number: 2056 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient
Abdelmoneim Helal¹, Dia MF Mohasseb², Noha AH El-Sawy² and Yousra H. Abdel-Fattah³, ¹Physical Medicine, Rheumatology & rehabilitation, Professor, Alexandria, Egypt, ²Physical Medicine, Rheumatology and Rehabilitation, Professor, Alexandria, Egypt, ³Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Background/Purpose: Fibromyalgia (FM) has been promoted as the commonest cause of chronic, widespread non-articular musculoskeletal pain, stiffness and fatigue. Although pain is the central feature…
Abstract Number: 1811 • 2014 ACR/ARHP Annual Meeting
The Burden of Depression on Healthcare Utilization in a Population-Based Cohort of Patients with Systemic Lupus Erythematosus
Alfredo Aguirre¹, Gaobin Bao², S. Sam Lim³ and Cristina Drenkard⁴, ¹Department of Rheumatology, Emory University, Atlanta, GA, ²Medicine, Emory University, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . Systemic lupus erythematosus (SLE) is a chronic disease that disproportionately strikes black women. Depression is a potentially debilitating co-morbidity that affects 15-75% of…
Abstract Number: 1103 • 2013 ACR/ARHP Annual Meeting
Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia
Able Lawrence, Venkatesh Pai, Rajni Srivastava, Vikas Agarwal, Ramnath Misra and Amita Aggarwal, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Background/Purpose: Secondary Fibromyalgia is seen in 15% of patients with rheumatoid arthritis (RA). Neurotrophins are elevated in patients with active arthritis and BDNF is elevated…
Abstract Number: 1097 • 2013 ACR/ARHP Annual Meeting
A Potential Use Of Neurotropin^TM, a Novel Neuro-Modulating Medication, For The Treatment Of Chronic Pain and Fibromyalgia
Kenji Miki^1,2,3, Ryota Hashimoto^4,5,6, Kenrin Shi^2,7,8 and Masao Yukioka⁸, ¹Department of Orthopaedic Surgery, Amagasaki Central Hospital, Amagasaki, Japan, ²Center for Pain Management, Osaka University Hospital, Suita, Japan, ³Dept. of Rheumatology, Yukioka Hospital, Osaka, Japan, ⁴Dept of Rheumatology, Yukioka Hospital, Osaka, Japan, ⁵Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan, ⁶Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan, ⁷Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan, ⁸Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan
Background/Purpose: To date, no established treatment for chronic pain including fibromyalgia has been specified in Japan. Neurotropin, a non-protein extract isolated from the inflamed cutaneous…
Abstract Number: 1104 • 2013 ACR/ARHP Annual Meeting
Quality Of Life and Burden Of Ehlers-Danlos Syndrome (EDS) Type III
Marion Geoffroy¹, Christelle Guillaume¹, Amélie Servettaz¹, Violaine Laurant-Noel¹, Christine Serratrice Sr.², Jacques Serratrice³, Boris Bienvenu⁴ and Roland Jaussaud⁵, ¹Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré. CHU de Reims, Reims, France, ²internal medicine, Foundation Hopital Saint Joseph, Marseille, France, ³Hôpital de la Timone, Marseille, France, ⁴Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, ⁵Médecine interne, maladies infectieuses, immunologie clinique, CHU de Reims, REIMS, France
Background/Purpose: The Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders. Hypermobility type EDS is the most common type…
Abstract Number: 1073 • 2013 ACR/ARHP Annual Meeting
Longitudinal Decline In Steps/Day In Older Adults With Or At High Risk Of Knee OA
Daniel K. White¹, Roger Fielding², K. Douglas Gross³, Michael C. Nevitt⁴, Cora E. Lewis⁵, James Torner⁶ and Tuhina Neogi⁷, ¹Boston University School of Medicine, Boston, MA, ²Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, ³Physical Therapy, MGH Institute of Health Professions, Boston, MA, ⁴Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁵Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, ⁶Epidemiology, University of Iowa, Iowa City, Iowa City, IA, ⁷Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Walking is the most common type of physical activity older adults employ for physical activity, which, when performed regularly, confers important health benefits. When…
Abstract Number: 1088 • 2013 ACR/ARHP Annual Meeting
Fibromyalgia and Parental Medical Histories Of Depression and Alcoholism
Robert S. Katz¹, Ben J. Small², Sharon M. Ferbert³ and Susan Shott⁴, ¹Rush Medical College, Chicago, IL, ²Rush University Medical School, Chicago, IL, ³Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: We had found in a previous study suggestions of an increased prevalence of depression in the mothers and alcohol abuse in the fathers of…
Abstract Number: 1033 • 2013 ACR/ARHP Annual Meeting
Psychological status correlates of disease activity and sleep quality in patients with Ankylosing Spondylitis: A case-control study
Mingcan Yang¹, Yutong Jiang², Zhiming Lin³, Zetao Liao⁴, Qiuxia Li⁴, Yanli Zhang¹ and Jieruo Gu⁵, ¹Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Rheumatology, Third affiliated hospital of Sun Yat-sen University, Guangzhou, China, ³Rheumatology, third affiliated hospital of Sun Yat-sen Universtiy, Guangzhou, China, ⁴Rheumatology, The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, ⁵Medicine, Third Affiliated Hospital of Sun Yat-sen University, GuangZhou, China
Background/Purpose: The objective of this study was to compare psychological status and sleep quality between the patients with AS patients and healthy controls, and to discover the correlation between anxiety, depression and sleep disturbances, to evaluate the associated factors of disease specific variables in AS patients and to detect independent factors contributing to psychological variables. Methods: A nationwide face-to-face epidemiological investigation was performed in multiple centers of China. The demographic data , clinical symptoms/signs and psychological assessment data including Zung self-rating anxiety scale (SAS), Zung self-rating depression scale (SDS) and the Pittsburgh Sleep Quality Index questionnaire (PSQI) were collected using questionnaires. Mann-Whitney U test and t test was used in independent groups for parametric variables, whereas the Spearman correlation analysis and multiple stepwise regression analysis were used to assess correlation between parametric variables. Results: 683 AS patients by the revised New York criteria for AS and 697 age-, sex-, education-matched healthy controls were enrolled in the study.(1) Compared with healthy controls, AS patients suffered from more severe psychological disorders and sleep disturbance（P
Abstract Number: 1036 • 2013 ACR/ARHP Annual Meeting
The Independent Impact Of Depression On Incident Myocardial Infarction In Psoriatic Disease: A Population-Based Cohort Study
Lindsay C Burns^1,2, Jan P. Dutz¹ and Hyon Choi^3,4,5, ¹Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ²Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Psoriasis (PsC) and psoriatic arthritis (PsA) represent common, lifelong inflammatory diseases of the skin and joints (respectively) that are associated with substantial cardiovascular and…
Abstract Number: L6 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Co-Morbid Depression Receiving Concurrent Antidepressant Therapy: A Randomized, 2-Way Crossover, Double-Blind, Placebo-Controlled Study
Lesley M. Arnold¹, Piercarlo Sarzi-Puttini², Pierre Arsenault³, Tahira Khan⁴, Pritha Bhadra Brown⁵, Andrew Clair⁵, Joseph Driscoll⁴, Jaren Landen⁴ and Lynne Pauer⁴, ¹Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, ²Azienda Ospedaliera Polo Universitario L. Sacco, Milano, Italy, ³Département de Médecine de Famille, Université de Sherbrooke, Sherbrooke, QC, Canada, ⁴Pfizer Inc, Groton, CT, ⁵Pfizer Inc, New York, NY
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and often associated with mood disorders including depression. Approximately 50–70% of FM patients have a lifetime…
Abstract Number: 2716 • 2013 ACR/ARHP Annual Meeting
Support For Psychological State May Be Effective to Attain Remission Of Boolean-Based Definition Of Patient Global Assessment In Patients With Rheumatoid Arthritis
Mie Fusama¹, Kumiko Yukioka², Takanori Kuroiwa³, Chikako Yukioka⁴, Miyako Inoue², Tae Nakanishi², Norikazu Murata⁴, Noriko Takai⁵, Kayoko Higashi⁶, Taro Kuritani⁷, Keiji Maeda⁷, Yasushi Miura¹, Hajime Sano⁸, Masao Yukioka⁴ and Hideko Nakahara⁹, ¹Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, ²Division of Clinical Psychology, Yukioka Hospital, Osaka, Japan, ³Department of Rheumatology, Yukioka Hospital, Osaka, Japan, ⁴Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan, ⁵Division of Clinical Psychology, Yukioka College of Health Science, Osaka, Japan, ⁶Division of nursing, NTT West Osaka Hospital, Osaka, Japan, ⁷Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, ⁸Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya-city, Japan, ⁹Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan
Background/Purpose: The patients with rheumatoid arthritis (RA) often do not meet patient global assessment (PGA) remission criterion despite a good clinical disease state and, therefore,…
Abstract Number: 2446 • 2013 ACR/ARHP Annual Meeting
Opiate Use In Patients With Ankylosing Spondylitis
John D. Reveille¹, Michael M. Ward², MinJae Lee³, Mohammad Rahbar⁴, Manouchehr Ardjomand-Hessabi⁵, Laura A. Diekman⁵, Matthew A. Brown⁶, Lianne S. Gensler⁷ and Michael H. Weisman⁸, ¹Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ²Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, ³Medicine, University of Texas Health Science Center at Houston, Houston, TX, ⁴The University of Texas Health Science Center at Houston, Houston, TX, ⁵Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX, ⁶Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia, ⁷Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁸Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA
Background/Purpose: Prescription opiates are commonly prescribed in patients with chronic pain, yet there is no evidence that these drugs ameliorate disease progression, and are associated with numerous…
Abstract Number: 2297 • 2013 ACR/ARHP Annual Meeting
Evaluating Depression Questionnaires In German Rheumatoid Arthritis Patients – Preliminary Results From a Validation Study
Matthias Englbrecht¹, Rieke Alten², Martin Aringer³, Christoph G. Baerwald⁴, Harald Burkhardt⁵, Nancy Eby⁶, Gerhard Fliedner⁷, Bettina Gauger⁸, Ulf Henkemeier⁹, Michael Hofmann¹⁰, Stefan Kleinert¹¹, Christian Kneitz¹², Christoph Pohl¹³, Georg Schett¹, Marc Schmalzing¹⁴, Anne-Kathrin Tausche¹⁵, Hans Peter Tony¹⁶ and Joerg Wendler¹⁷, ¹Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Teaching Hospital of the Charité, University of Berlin, Berlin, Germany, ³Rheumatology, Medicine III, University Clinical Center Technical University of Dresden, Dresden, Germany, ⁴Rheumatology, University Hospital, Leipzig, Germany, ⁵CIRI /Div. of Rheumatology, Goethe-University, Frankfurt/Main, Germany, ⁶Biostatistics, AMS-Advanced Medical Services, Mannheim, Germany, ⁷Praxis Osnabrück, Germany, Germany, Osnabrück, Germany, ⁸Roche Pharma AG, Grenzach, Germany, ⁹University Hospital Frankfurt, Frankfurt, Germany, ¹⁰Chugai Pharma, Frankfurt, Germany, ¹¹Rheumatology/Clinical Immunology,, University Hospital Würzburg, Würzburg, Germany, ¹²Internal Medicine II, Hospital Südstadt, Rostock, Germany, ¹³Rheumatology,Clinical Immunolo, Schlosspark Klinik, Berlin, Germany, ¹⁴Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, ¹⁵Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, ¹⁶Rheumatology/Immunology, University of Würzburg, Würzburg, Germany, ¹⁷Schwerpunktpraxis Rheumatologie, Erlangen, Germany
Background/Purpose: To date, only a few studies have discussed the prevalence of depression in RA patients in Germany and depression questionnaires have not been validated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].